Dxn Stock

Dxn P/S

The (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Dxn (DXN.AX) as of Jul 25, 2026 is 0.44. In the previous year, (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. was 0.64 — a change of -31.69% (lower).

P/S

0.44

YoY

-31.69%

Last updated:

As of Jul 25, 2026, Dxn's P/S ratio stood at 0.44, a -31.69% change from the 0.64 P/S ratio recorded in the previous year.

The Dxn P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2019
0.00 base
Jan 1, 2020
0.52 base
Jan 1, 2021
0.02 base
Jan 1, 2022
0.01 base
Jan 1, 2023
0.22 base
Jan 1, 2024
0.75 base
Jan 1, 2025
0.60 base
Jan 1, 2026 (e)
2.42 base
YEARP/S
2026 est 2.42
2025 0.60
2024 0.75
2023 0.22
2022 0.01
2021 0.02
2020 0.52
2019 -
2018 -
Access this data via the Eulerpool API

Dxn Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Dxn's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Dxn's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Dxn's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Dxn grows earnings faster than its peers.

Dxn Stock analysis

What does Dxn do? DXN Ltd is a leading global company in the health and wellness industry, headquartered in Malaysia. The company was founded in 1993 by Dato' Dr. Lim Siow Jin, who developed a revolutionary business model to offer high-quality dietary supplements and healthy beverages. The goal was to enable people worldwide to have a better and healthier life. The history of DXN Ltd began over 25 years ago when Dato' Dr. Lim Siow Jin discovered his passion for herbal medicine and started researching medicinal mushrooms. Initially, it was difficult to garner people's interest in herbal medicine. However, over time, the company became increasingly successful and interest in its products grew. DXN Ltd has developed a unique business model that allows people to build a business in the health and wellness industry while selling healthy products. DXN refers to this as the "One Dragon, One World, One Market" concept. This means that DXN focuses on selling products based on natural ingredients and markets them through a network of distributors worldwide. DXN Ltd offers various product lines. One of its most well-known products is "Lingzhi Coffee," which is made from natural ingredients and contains all the benefits of "Lingzhi," a medicinal mushroom. The company also offers other coffee varieties, tea, dietary supplements, and skincare products. The dietary supplements offered by DXN Ltd are based on natural ingredients such as mushrooms and herbs. Each product is carefully manufactured and tested to ensure the highest quality. DXN Ltd has received many patents for its products and is known for its innovative offerings. The company also provides a comprehensive training program for its distributors to ensure that they understand the products and the business model and can market them successfully. DXN Ltd has built a global network of distributors registered in over 180 countries. DXN Ltd has received many awards for its products and business model. It has been named "Company of the Year" by Direct Selling News Magazine and has also received the "Reader's Digest Asia Trusted Brand Award" for its outstanding products and services. DXN Ltd is committed to continued growth and expanding its range of healthy products. The company also actively promotes environmental protection and engages in various charitable activities to give back to society. In summary, DXN Ltd is an innovative and future-oriented company dedicated to promoting a healthy and better life for people worldwide. With its high-quality products and unique business model, the company has achieved a strong position in the health and wellness industry. Dxn is one of the most popular companies on Eulerpool.

P/S Details

Decoding Dxn's P/S Ratio

Dxn's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Dxn's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Dxn's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Dxn’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Dxn stock

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Dxn is 0.44 in 2026.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — Dxn

All Key Metrics — Dxn